Embedded Files
Proprietary LEA Hybrid Platforms
Proprietary LEA Hybrid Platforms
Our discovery engine utilizes specialized LEA hybrids to modulate neurotransmitter and metabolic pathways:
Dopamine/Serotonin Hybrids
Dopamine/Serotonin Hybrids
Targeted for CNS regulation in addictive diseases and PD.
GABA Hybrids
GABA Hybrids
Engineered for inhibitory signaling modulation in neurodegenerative contexts.
Cysteine Hybrids
Cysteine Hybrids
Optimized for antioxidant delivery and metabolic cellular defense.
Visualizing The LEA Hybrid Mechanism
Visualizing The LEA Hybrid Mechanism
To help visitors understand how your lipid-based therapeutics work, a diagram of a lipid nanoparticle or hybrid delivery system is essential.
Our Team
Our Team
Brent Reynolds, PhD
Scientific Consultant
Professor of Neurosurgery University of
Florida
Brent Reynolds, PhD
Scientific Consultant
Professor of Neurosurgery University of
Florida
Stanislav Svetlov, MD/PhD
Founder
Chief Scientific Officer, Immunova,
LLC
Stanislav Svetlov, MD/PhD
Founder
Chief Scientific Officer, Immunova,
LLC
Page updated
Report abuse